← Eichor
Study identifier: NCT05973656 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Role of Acetaldehyde in the Development of Oral Cancer

Condition: Alcohol-Related Carcinoma · Fanconi Anemia · Oral Cavity Carcinoma  ·  Sponsor: Masonic Cancer Center, University of Minnesota

PhaseNA
Planned participants170
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersYes

About this study

This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primarily non-invasive biological samples at various time points. Biospecimens to be collected include saliva, oral cells collected via mouthwash and cheek brush, and urine. The collection of two blood samples (5 mL each) will be optional and banked for future use.

This description comes directly from the study's public registry record.

Talk to the study team

Balbo Silvia, PhD  ·  612-624-4240  ·  balbo006@umn.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Masonic Cancer Center, University of MinnesotaMinneapolis, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05973656